What is it about?
Bronchial epithelial cell damage occurs in patients with bronchial asthma. This study shows that decreased ezrin induced by IL-13 is involved in the defective epithelial barrier function in asthma and might be a potential biomarker of asthma control.
Featured Image
Read the Original
This page is a summary of: Ezrin, a Membrane Cytoskeleton Cross-Linker Protein, as a Marker of Epithelial Damage in Asthma, American Review of Respiratory Disease, February 2019, American Thoracic Society,
DOI: 10.1164/rccm.201802-0373oc.
You can read the full text:
Contributors
The following have contributed to this page
